Grown Rogue Reports Second Quarter 2022 Results, 26% Sequential Revenue Growth, Positive Net Income and Record aEBITDA1


Ryan Allway

June 30th, 2022

News, Top News


  • Revenue of $4.70M compared to $1.54M in Q2 2021, an increase of 206%, with aEBITDA margin improvement to 26.7% compared to 11.7% in Q2 2021
  • Operating Cash Flow, before changes in working capital, of $1.08M or 22.9% of revenue
  • Fourth consecutive quarter of positive operating cash flow and net income

 

MEDFORD, Ore.June 30, 2022 /CNW/ – Grown Rogue International Inc. (“Grown Rogue” or the “Company”) (CSE: GRIN) (OTC: GRUSF), a multi-state cannabis company with operations and assets in Oregon and Michigan, reports fiscal second quarter 2022 results for the three months ended April 30, 2022. All financial information is provided in U.S. dollars unless otherwise indicated.

 

Second Quarter 2022 Financial Summary

  • Ninth consecutive quarter of positive aEBITDA1
  • Fourth consecutive quarter of positive net income and positive operating cash flow, before changes in working capital
  • Launched nitrogen sealed pre-rolls in Michigan
  • Harvested first crops from the newly constructed 11th and 12th flower rooms in Michigan and began construction on the 13th and 14th rooms with first harvests expected in fiscal Q4
  • Top 10 flower brand in Michigan, according to LeafLink’s MarketScape data
  • #1 flower brand in Oregon for the fourth consecutive quarter, according to LeafLink’s MarketScape data
  • Named fastest growing brand in Oregon during April, according to LeafLink; the fourth time in eight months
  • Subsequent to quarter-end, completed a $0.70M debt settlement with the exchange of 2.36M shares of PBIC, that held a value of less than $0.16M on the transaction date

 

“Grown Rogue had another very strong quarter, reporting positive operating cash flow, net income, and free cash flow,” said Obie Strickler, CEO of Grown Rogue. “In Q2, we estimate we had one of the lowest average indoor selling price of any public cannabis company at $872 per pound of whole flower ($1.92 per gram) while reporting 23% operating cash flow margins, before changes in working capital”, continued Mr. Strickler. “We continue to evaluate opportunities for new markets where we can bring our craft quality and efficiencies to provide better access for patients and consumers. Oregon had a particularly strong quarter with revenue up 70% quarter over quarter even while the overall market was down slightly. The Company launched pre-rolls in Michigan during the quarter and we are excited about the initial receptivity in this category. I could not be more proud of our team as we were north of $1M in aEBITDA for the third consecutive quarter and have established Grown Rogue as the consistent  market leader in the Oregon flower market, one of the most competitive states in the US. We are laser focused on continuing to become more efficient, while staying on trend with leading genetics and quality.”

 

Highlights by State

Oregon Operations

  • Revenue of $2.36M compared to $1.37M in Q2 2021, an increase of 72%
  • Gross profit, before fair value adjustments, of $1.03M compared to $0.59M in Q2 2021, an increase of 74%
  • Gross margin, before fair value adjustments, of 43.7%
  • Segmented aEBITDA of $0.62M and aEBITDAmargin of 26.5% compared to segmented aEBITDA1 of $0.18M and aEBITDA1 margin of 11.7% in Q2 2021
  • Average selling price of indoor whole flower of $719/pound
  • Monthly indoor production increased to approximately 800 pounds of whole flower in Q2 2022, with expectations to be at or near 1,000 pounds per month in Q3

 

 

Michigan Operations (Through Golden Harvests, LLC)

  • Revenue of $2.34M compared to pro-formarevenue of $1.38M in Q2 2021, an increase of 70%
  • Gross margin, before fair value adjustments, of 64.2%
  • Segmented aEBITDA1 of $1.16M and aEBITDA1 margin of 49.5% compared to pro-forma2 segmented aEBITDA1 of $0.34M and aEBITDA1 margin of 24.3% in Q2 2021
  • Average selling price of indoor whole flower of $1,182/pound
  • Monthly indoor production of whole flower increased to approximately 550 pounds in Q2 2022, with expectations to be at or near 750 pounds per month in Q3

 

April 30, 2022

October 31, 2021

$

$

ASSETS

Current assets

Cash

1,817,048

1,114,033

Accounts receivable (Note 20)

1,003,286

739,248

Biological assets (Note 4)

1,708,208

1,188,552

Inventory (Note 5)

3,211,404

3,306,312

Prepaid expenses and other assets

329,101

357,541

Total current assets

8,069,047

6,705,686

Marketable securities (Note 6)

404,108

610,092

Other investments and purchase deposits (Note 8)

750,000

Property and equipment (Note 11)

8,369,636

5,742,584

Intangible assets and goodwill (Note 12)

725,668

399,338

TOTAL ASSETS

17,568,459

14,207,700

LIABILITIES

Current liabilities

Accounts payable and accrued liabilities

1,913,163

1,766,707

Current portion of lease liabilities (Note 10)

1,053,827

624,935

Current portion of long-term debt (Note 13)

1,778,183

843,900

Business acquisition consideration payable (Note 7)

360,000

358,537

Interest payable (Note 13)

15,000

13,750

Unearned revenue

44,122

Income tax

294,365

254,631

Total current liabilities

5,458,660

3,862,460

Accrued liabilities (Note 9)

60,514

123,413

Lease liabilities (Note 10)

1,572,778

1,735,503

Long-term debt (Note 13)

1,675,057

1,365,761

TOTAL LIABILITIES

8,767,009

7,087,137

EQUITY

Share capital (Note 14)

21,858,827

20,499,031

Shares issuable (Note 7)

35,806

74,338

Contributed surplus (Notes 15, 16)

6,483,074

6,407,935

Accumulated other comprehensive loss

(106,069)

(90,378)

Accumulated deficit

(21,190,996)

(21,804,349)

Equity attributable to shareholders

7,080,642

5,086,577

Non-controlling interests (Note 24)

1,720,808

2,033,986

TOTAL EQUITY

8,801,450

7,120,563

TOTAL LIABILITIES AND EQUITY

17,568,459

14,207,700

Three months ended April 30,

2022

2021

Revenue

Product sales

4,700,127

1,370,728

Service revenue (Note 7)

167,694

Total revenue

4,700,127

1,538,422

Cost of goods sold

Cost of finished cannabis inventory sold (Note 5)

(2,165,447)

(875,078)

Costs of service revenues (Note 7)

(70,200)

Gross profit, excluding fair value items

2,534,680

593,144

Realized fair value amounts in inventory sold

(981,113)

(19,732)

Unrealized fair value gain (loss) on growth of biological assets (Note 4)

670,135

33,754

Gross profit

2,223,702

607,166

Expenses

Accretion expense

137,792

366,079

Amortization of intangible assets

Amortization of property and equipment (Note 11)

239,683

40,546

General and administrative (Note 21)

1,469,533

775,919

Share-based compensation

30,999

47,572

Total expenses

1,878,007

1,230,116

Gain (loss) from operations

345,695

(622,950)

Other income and (expense)

Interest expense

(110,901)

(36,361)

Other income (expense)

(1,366)

(22,319)

Gain on debt settlement

114,997

Loss on settlement of non-controlling interest

(189,816)

Unrealized gain (loss) on marketable securities

(19,082)

253,300

Unrealized loss on derivative liability

(939,369)

Gain on disposal of property and equipment

Gain (loss) from operations before taxes

214,346

(1,442,518)

         Income tax

(69,612)

Net income (loss)

144,734

(1,442,518)

Oregon

Michigan

Corporate

Consolidated

Sales revenues

2,357,439

2,342,688

4,700,127

Costs of goods sold, excluding fair value adjustments

(1,326,487)

(838,960)

(2,165,447)

Gross profit (loss) before fair value adjustments

1,030,952

1,503,728

2,534,680

Net fair value adjustments

(217,577)

(93,401)

(310,978)

Gross profit

813,375

1,410,327

2,223,702

Operating expenses:

General and administration

517,051

423,460

529,022

1,469,533

Depreciation and amortization

13,564

196,024

30,095

239,683

Share based compensation

30,999

30,999

Other income and expense:

Gain on sale of assets

Interest and accretion

67,766

73,465

107,462

248,693

Unrealized loss (gain) on marketable securities

19,082

19,082

Other income and expense

1,366

1,366

Net income (loss) before tax

214,994

717,378

(718,026)

214,346

Tax

8,395

61,217

69,612

Net income after tax

206,599

656,161

(718,026)

144,734

Three months ended

April 30,

Adjusted EBITDA Reconciliation

2022 ($)

2021 ($)

Net income (loss), as reported

144,734

(1,442,518)

Add back realized fair value amounts included in inventory sold

981,113

19,732

Add back (deduct) unrealized fair value loss on growth of biological assets

(670,135)

(33,754)

Add back amortization of property & equipment included in cost of sales

190,164

246,728

645,876

(1,209,812)

Add back interest and interest accretion expense, as reported

248,693

402,440

Add back amortization of intangible assets, as reported

Add back amortization of property and equipment, as reported

239,683

40,546

Add back share-based compensation

34,107

47,572

Add back (deduct) unrealized loss (gain) on marketable securities, as reported

19,082

(253,300)

Add back unrealized loss on derivative liability

939,369

Add back unrealized foreign exchange loss

22,927

Loss on settlement of non-controlling interest

189,816

Add back income tax expense

69,612

 EBITDA and aEBITDA

1,257,053

179,558

 

About Grown Rogue

Grown Rogue International (CSE: GRIN | OTC: GRUSF) is a vertically integrated, multi-state Cannabis family of brands on a mission to inspire consumers to “enhance experiences” through cannabis. We have combined an expert management team, award winning grow team, state of the art indoor and outdoor manufacturing facilities, and consumer insight-based product categorization, to create innovative products thoughtfully curated from “seed to experience.”  The Grown Rogue family of products include sungrown and indoor premium flower, along with nitro sealed indoor and sungrown pre-rolls and jars.

 

 

NOTES:

1.

The Company’s “aEBITDA,” or “Adjusted EBITDA,” is a non-IFRS measure used by management that does not have any prescribed meaning by IFRS and that may not be comparable to similar measures presented by other companies. The Company defines “EBITDA” as the Company’s net income or loss for a period, as reported, before interest, taxes, depreciation and amortization, and is further adjusted to remove transaction costs, stock-based compensation expense, accretion expense, gain (loss) on derecognition of derivative liabilities, the effects of fair-value accounting for biological assets and inventory, as well as other non-cash items and items not representative of operational performance as reported in net income (loss). Adjusted EBITDA is defined as EBITDA adjusted for the impact of various significant or unusual transactions. The Company believes that this is a useful metric to evaluate its operating performance.

2.

The Company has provided unaudited pro-forma revenue information, which assumes that closed and pending mergers and acquisitions in 2021 are included in the Company’s financial results as of the beginning of the quarterly and annual periods in 2021 for the Company and target companies.

 

 

NON-IFRS FINANCIAL MEASURES

EBITDA and aEBITDA are non-IFRS measures and do not have standardized definitions under IFRS. The Company has also provided unaudited pro-forma financial information, which assumes that closed and pending mergers and acquisitions in 2021 are included in the Company’s financial results as of the beginning of the quarterly and annual periods in 2021. The Company has provided the non-IFRS financial measures, which are not calculated or presented in accordance with IFRS, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with IFRS. These supplemental non-IFRS financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-IFRS financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-IFRS financial measures should not be considered superior to, as a substitute for or as an alternative to, and should only be considered in conjunction with, the IFRS financial measures presented herein. Accordingly, the following information provides reconciliations of the supplemental non-IFRS financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with IFRS.

 

 

About Grown Rogue

Grown Rogue International (CSE: GRIN | OTC: GRUSF) is a vertically integrated, multi-state Cannabis family of brands on a mission to inspire consumers to “enhance experiences” through cannabis. We have combined an expert management team, award winning grow team, state of the art indoor and outdoor manufacturing facilities, and consumer insight-based product categorization, to create innovative products thoughtfully curated from “seed to experience.”  The Grown Rogue family of products include sungrown and indoor premium flower, along with nitro sealed indoor and sungrown pre-rolls and jars.

 

 

FORWARD-LOOKING STATEMENTS

This press release contains statements which constitute “forward–looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities. Forward– looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and include information regarding: (i) statements regarding the future direction of the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion of the Company into Michigan and securing applicable regulatory approvals, and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward–looking information is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning the business of the Company’s future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward–looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward–looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related costs, and other risks described in the Company’s public disclosure documents filed on Sedar.

 

 

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward–looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward–looking information except as otherwise required by applicable law.

 

 

SAFE HARBOR STATEMENT

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the Company’s Form 20-F and 6-K filings with the Securities and Exchange Commission.

 

 

The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company’s business are disclosed in the Company’s Listing Statement filed on its issuer profile on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

 

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

SOURCE Grown Rogue International Inc.

 

For further information: For further information on Grown Rogue International please visit www.grownrogue.com or contact: Obie Strickler, Chief Executive Officer, [email protected], Investor Relations Desk Inquiries , [email protected], (458) 226-2100

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading